Conditioning regimens for HSCT
From IDWiki
Revision as of 21:49, 16 June 2020 by Aidan (talk | contribs) (Created page with "{| class="wikitable" ! Regimen ! Drugs ! Comments |- ! colspan=3 | Myeloablative regimens |- | BEAM | Carmustine, etoposide, cytosine arabinoside, and [[melphalan]...")
| Regimen | Drugs | Comments |
|---|---|---|
| Myeloablative regimens | ||
| BEAM | Carmustine, etoposide, cytosine arabinoside, and melphalan | Commonly used for non-Hodgkin and Hodgkin lymphoma |
| Cy/TBI | Cyclophosphamide and TBI | |
| Bu4/Cy | Busulfan and cyclophosphamide | |
| Flu/Bu4 | Busulfan and fludarabine for four days | |
| High-dose melphalan | Melphalan | Used in preparation for autoHSCT in myeloma |
| CBV | Carmustine once followed by etoposide and cyclophosphamide for four days | |
| Reduced-intensity regimens | ||
| Flu/Mel | Fludarabine and melphalan | |
| Flu/Bu2 and Flu/Bu3 | Fludarabine and busulfan | |
| Flu/Cy | Fludarabine and cyclophosphamide | |
| Flu/Bu3/TT | Fludarabine, busulfan, and thiotepa | |
| Non-myeloablative regimens | ||
| Flu/TBI | Fludarabine and TBI | |
| TLI/ATG | Total lymphoid irradiation and anti-thymocyte globulin | |
| Low dose TBI | TBI | |
TBI = total body irradiation
